What does the research say about Cardiovascular–kidney–metabolic comorbidities?

Cardiovascular–kidney–metabolic comorbidities

There are 2 papers on cardiovascular–kidney–metabolic comorbidities in aging research: 2 observational studies in people. The newest story, Oct 30, 2026: “Kidney disease linked to metabolic fatty liver disease both ways”.

Disease

2 papers study it3 more mention it1 finding

3 new papers in 30 daysSee all 5

“Each additional cardiovascular-kidney-metabolic comorbidity was associated with higher operational CKD odds (OR = 1.64, 95% CI = 1.56-1.72; P < 0.001).”

Bidirectional associations and shared plasma proteomic signatures of CKD and MASLD: evidence from a population-based prospective cohort and a real-world hospital cohortNutrition, metabolism, and cardiovascular diseases : NMCD2026doi:10.1016/j.numecd.2026.105039

Humans2

Associations

Chronic kidney disease

upin humans1OR 1.64

1 study

Cardiovascular–kidney–metabolic comorbidities are associated with chronic kidney disease in humans (Chinese hospital patients with coding-defined MASLD; operational CKD definition) (OR 1.64 per additional comorbidity, 95% CI 1.56–1.72).
“Each additional cardiovascular-kidney-metabolic comorbidity was associated with higher operational CKD odds (OR = 1.64, 95% CI = 1.56-1.72; P < 0.001).”
HumansChinese hospital patients with coding-defined MASLD; operational CKD definitionEach additional cardiovascular-kidney-metabolic comorbidityn = 32,898
Kidney disease linked to metabolic fatty liver disease both ways
Nutrition, metabolism, and cardiovascular diseases : NMCDOct 19, 2026

Latest

4 papers in 12 months

Nutrition, Metabolism, and Cardiovascular DiseasesOct 30

Kidney disease linked to metabolic fatty liver disease both ways

Chronic kidney disease was linked to later metabolic fatty liver disease (hazard ratio 1.36); the reverse link had a ratio of 1.64, versus people without each condition.Chronic kidney disease was linked to later metabolic fatty liver disease (hazard ratio 1.36); the reverse link had a ratio of 1.64, versus people without each condition.

Cohort · 462,516 peopleBiomarkers